EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Tumour microenvironment changes after osimertinib treatment resistance in non-small cell lung cancer

Ruoshuang Han, Haoyue Guo, Jinpeng Shi, Haowei Wang, Sha Zhao, Yijun Jia, Xiaozhen Liu, Jiayu Li, Lei Cheng, Chao Zhao, Xuefei Li, Caicun Zhou

European Journal of Cancer · 2023-08 · 189 · 112919

DOI: 10.1016/j.ejca.2023.05.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2023-08. Verfasst von Ruoshuang Han und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, PR China; Department of Oncology, Southw…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, MicroRNAs, Exosomes. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsMicroRNAsExosomesHumansCD8-Positive T-LymphocytesTumor MicroenvironmentLeukocytes, MononuclearCell Line, TumorAcrylamidesAniline CompoundsIndolesPyrimidines

Stichwörter der Autor:innen

ExosomeMacrophageNSCLCOsimertinibT cellsTumour microenvironment

Substanzen

MicroRNAsosimertinibAcrylamidesAniline CompoundsIndolesPyrimidinesMIRN1258 microRNA, human

Autor:innen und Institutionen

  • Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, PR China; Department of Oncology, Southwest Hospital, Third Military Medical University, Chongqing, PR China.
  • Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, PR China.
  • Department of Lung Cancer and Immunology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, PR China.
  • Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, PR China. Electronic address: caicunzhoudr@yeah.net.

Zitieren

APA

Han, R., Guo, H., Shi, J., Wang, H., Zhao, S., Jia, Y., Liu, X., Li, J., Cheng, L., Zhao, C., Li, X., & Zhou, C. (2023). Tumour microenvironment changes after osimertinib treatment resistance in non-small cell lung cancer. European Journal of Cancer, 189, 112919. https://doi.org/10.1016/j.ejca.2023.05.007

Vancouver

Han R, Guo H, Shi J, Wang H, Zhao S, Jia Y, et al. Tumour microenvironment changes after osimertinib treatment resistance in non-small cell lung cancer. European Journal of Cancer. 2023;189:112919. doi:10.1016/j.ejca.2023.05.007

BibTeX
@article{Han2023,
  author = {Han, Ruoshuang and Guo, Haoyue and Shi, Jinpeng and Wang, Haowei and Zhao, Sha and Jia, Yijun and Liu, Xiaozhen and Li, Jiayu and Cheng, Lei and Zhao, Chao and Li, Xuefei and Zhou, Caicun},
  title = {Tumour microenvironment changes after osimertinib treatment resistance in non-small cell lung cancer},
  journal = {European Journal of Cancer},
  year = {2023},
  volume = {189},
  pages = {112919},
  doi = {10.1016/j.ejca.2023.05.007}
}
Kostenlos starten →